Financial Management Professionals Inc. Purchases Shares of 2,629 Privia Health Group, Inc. (NASDAQ:PRVA)

Financial Management Professionals Inc. bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,629 shares of the company’s stock, valued at approximately $51,000.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Park Avenue Securities LLC grew its stake in shares of Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after buying an additional 532 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Privia Health Group by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after acquiring an additional 583 shares during the period. Benjamin F. Edwards & Company Inc. lifted its holdings in Privia Health Group by 8.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after purchasing an additional 605 shares during the last quarter. GAMMA Investing LLC boosted its position in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares during the period. Finally, KBC Group NV increased its holdings in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares during the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

PRVA has been the subject of several research reports. Truist Financial lifted their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Barclays lifted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. JPMorgan Chase & Co. raised their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Finally, Stephens restated an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $24.88.

Privia Health Group Trading Up 1.8 %

Shares of Privia Health Group stock opened at $22.24 on Monday. The company’s 50-day moving average price is $21.01 and its 200-day moving average price is $19.62. The company has a market cap of $2.67 billion, a price-to-earnings ratio of 222.42, a PEG ratio of 2.77 and a beta of 0.85. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $23.24.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.